- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/06 - Antimigraine agents
Patent holdings for IPC class A61P 25/06
Total number of patents in this class: 1292
10-year publication summary
|
44
|
46
|
89
|
87
|
124
|
125
|
120
|
125
|
94
|
63
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Axsome Therapeutics, Inc. | 253 |
53 |
| H. Lundbeck A/S | 1247 |
42 |
| Merck Sharp & Dohme LLC | 3748 |
38 |
| Allergan Pharmaceuticals International Limited | 226 |
35 |
| Eli Lilly and Company | 3842 |
25 |
| Boehringer Ingelheim International GmbH | 4650 |
19 |
| Amgen Inc. | 4074 |
19 |
| Takeda Pharmaceutical Company Limited | 2713 |
19 |
| Bristol-myers Squibb Company | 4898 |
17 |
| F. Hoffmann-La Roche AG | 7925 |
17 |
| Raqualia Pharma Inc. | 122 |
15 |
| Hoffmann-La Roche Inc. | 3418 |
12 |
| Sichuan Haisco Pharmaceutical Co., Ltd. | 151 |
11 |
| Janssen Pharmaceutica N.V. | 3392 |
10 |
| Taisho Pharmaceutical Co., Ltd. | 870 |
9 |
| Allergan, Inc. | 2349 |
8 |
| Heptares Therapeutics Limited | 77 |
8 |
| Intra-Cellular Therapies, Inc. | 411 |
8 |
| Vertex Pharmaceuticals Incorporated | 1597 |
7 |
| Dainippon Sumitomo Pharma Co., Ltd. | 194 |
7 |
| Other owners | 913 |